Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Autologous stem cell transplantation in acute myelocytic leukemia.

× No keyword cloud information.

10 in total

Review 1. Autologous stem cell transplantation in hematological malignancies.

Authors: Norbert-Claude Gorin
Journal: Springer Semin Immunopathol Date: 2004-10-07

2. T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.

Authors: Norbert-Claude Gorin; Myriam Labopin; Simona Piemontese; William Arcese; Stella Santarone; He Huang; Giovanna Meloni; Felicetto Ferrara; Dietrich Beelen; Miguel Sanz; Andrea Bacigalupo; Fabio Ciceri; Audrey Mailhol; Arnon Nagler; Mohamad Mohty
Journal: Haematologica Date: 2015-01-30 Impact factor: 9.941

3. Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission.

Authors: Norbert-Claude Gorin; Myriam Labopin; Giovanna Meloni; Arnaud Pigneux; Jordi Esteve; Mohty Mohamad
Journal: Haematologica Date: 2012-08-28 Impact factor: 9.941

4. Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors: Arnon Nagler; Myriam Labopin; Norbert-Claude Gorin; Felicetto Ferrara; Miguel A Sanz; Depei Wu; Antonio Torres Gomez; Simona Lapusan; Giuseppe Irrera; Jose E Guimaraes; Aida Botelho Sousa; Angelo M Carella; Norbert Vey; William Arcese; Avichai Shimoni; Raanan Berger; Vanderson Rocha; Mohamad Mohty
Journal: Haematologica Date: 2014-05-09 Impact factor: 9.941

Review 5. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects.

Authors: N-C Gorin; S Giebel; M Labopin; B N Savani; M Mohty; A Nagler
Journal: Bone Marrow Transplant Date: 2015-08-17 Impact factor: 5.483

6. Intensified daunorubicin in induction therapy and autologous peripheral blood stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute myeloid leukemia.

Authors: Noriko Usui; Nobuaki Dobashi; Osamu Asai; Shingo Yano; Yuichi Yahagi; Takeshi Saito; Yuko Yamaguchi; Kinuyo Kasama; Yutaka Okawa; Naohiro Sekiguchi; Yutaka Takei; Katsuki Sugiyama; Yoji Ogasawara; Hiroko Ohtsubo; Ken Kaito; Masayuki Kobayashi
Journal: Int J Hematol Date: 2002-12 Impact factor: 2.490

7. Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation.

Authors: Naveen Pemmaraju; Maria Florencia Tanaka; Farhad Ravandi; Heather Lin; Veerabhadran Baladandayuthapani; Gabriela Rondon; Sergio A Giralt; Julianne Chen; Sherry Pierce; Jorge Cortes; Hagop Kantarjian; Richard E Champlin; Marcos De Lima; Muzaffar H Qazilbash
Journal: Clin Lymphoma Myeloma Leuk Date: 2013-06-13

8. Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission: a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group.

Authors: Akio Kohno; Yoshihisa Morishita; Hiroatsu Iida; Masamitsu Yanada; Toshiki Uchida; Motohiro Hamaguchi; Masashi Sawa; Isamu Sugiura; Kazuhito Yamamoto; Shuichi Mizuta; Hiroshi Sao; Tomoki Naoe; Koichi Miyamura
Journal: Int J Hematol Date: 2008-02-28 Impact factor: 2.490

9. Cost-utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia.

Authors: A Gordois; P Scuffham; E Warren; S Ward
Journal: Br J Cancer Date: 2003-08-18 Impact factor: 7.640

10. Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia.

Authors: A Abdallah; G Egerer; R M Weber-Nordt; M Körbling; R Haas; A D Ho
Journal: Bone Marrow Transplant Date: 2002-07 Impact factor: 5.483

10 in total